SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-12-16 22:34
Tx date 2022-12-13 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-44,590
-91,000 vol
$0.49 each 		1,522,976
Filed 2022-12-16 22:33
Tx date 2022-12-12 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-77,910
-159,000 vol
$0.49 each 		1,613,976
Filed 2022-11-19 12:52
Tx date 2022-11-15 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+15,000 vol 		325,000
Filed 2022-07-20 18:50
Tx date 2022-07-15 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,100
-5,000 vol
$0.62 each 		1,772,976
Filed 2022-07-12 20:04
Tx date 2022-07-12 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-18,910
-30,500 vol
$0.62 each 		1,777,976
Filed 2022-07-12 20:04
Tx date 2022-07-11 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-25,730
-41,500 vol
$0.62 each 		1,808,476
Filed 2022-07-12 20:03
Tx date 2022-07-11 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-12,000
-20,000 vol
$0.60 each 		1,849,976
Filed 2022-07-12 20:02
Tx date 2022-07-08 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,270
-8,500 vol
$0.62 each 		1,869,976
Filed 2022-07-12 20:01
Tx date 2022-07-08 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,111
-5,100 vol
$0.61 each 		1,878,476
Filed 2022-07-12 20:00
Tx date 2022-07-08 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,600
-16,000 vol
$0.60 each 		1,883,576
Filed 2022-07-12 19:59
Tx date 2022-07-07 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-13,330
-21,500 vol
$0.62 each 		1,899,576
Filed 2021-11-19 20:39
Tx date 2021-11-15 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+75,000 vol 		1,164,200
Filed 2021-11-02 11:36
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,450
+17,000 vol
$0.85 each 		1,921,076
Filed 2021-11-02 11:36
Tx date 2021-11-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$27,720
+33,000 vol
$0.84 each 		1,904,076
Filed 2021-08-05 17:58
Tx date 2021-08-04 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,712
+10,300 vol
$1.04 each 		1,871,076
Filed 2021-06-06 16:18
Tx date 2021-06-02 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$1,460,188
+330,098 vol
$4.42 each 		442,729
Filed 2021-06-06 16:16
Tx date 2021-06-02 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$6,620,347
+1,496,631 vol
$4.42 each 		1,860,776
Filed 2021-03-06 12:40
Tx date 2021-03-03 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$256,104
+49,729 vol
$5.15 each 		364,145
Filed 2021-03-06 12:39
Tx date 2021-03-03 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$56,480
+10,967 vol
$5.15 each 		112,631
Filed 2021-03-03 20:08
Tx date 2021-03-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$765,775
+144,759 vol
$5.29 each 		314,416
Filed 2021-03-03 20:07
Tx date 2021-03-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$168,893
+31,927 vol
$5.29 each 		101,664
Filed 2021-02-27 16:45
Tx date 2021-02-23 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$860,215
+134,830 vol
$6.38 each 		169,657
Filed 2021-02-27 16:43
Tx date 2021-02-23 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$189,722
+29,737 vol
$6.38 each 		69,737
Filed 2021-01-15 18:55
Tx date 2021-01-11 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+484,200 vol 		1,089,200
Filed 2020-12-17 18:40
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation
-5,445,000 vol 		605,000
Filed 2020-12-17 18:39
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-2,790,000 vol 		310,000
Filed 2020-12-17 18:38
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-360,000 vol 		40,000
Filed 2020-12-17 18:37
Tx date 2020-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-313,443 vol 		34,827
Filed 2020-09-23 15:21
Tx date 2020-09-22 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$26,455
+71,500 vol
$0.37 each 		348,270
Filed 2020-06-06 13:39
Tx date 2020-06-04 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-77,100
-128,500 vol
$0.60 each 		400,000
Filed 2020-06-06 13:37
Tx date 2020-06-02 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-57,900
-96,500 vol
$0.60 each 		528,500
Filed 2020-06-06 13:34
Tx date 2020-06-04 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-405,000
-675,000 vol
$0.60 each 		276,770
Filed 2020-06-06 13:33
Tx date 2020-06-02 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-105,000
-175,000 vol
$0.60 each 		951,770
Filed 2020-06-06 13:31
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-990,000
-1,650,000 vol
$0.60 each 		1,126,770
Filed 2020-06-06 13:28
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$181,250
+1,250,000 vol
$0.145 each 		2,776,770
Filed 2020-06-06 13:27
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$28,000
+200,000 vol
$0.14 each 		1,526,770
Filed 2020-06-06 13:26
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$346,500
+1,050,000 vol
$0.33 each 		1,326,770
Filed 2020-06-06 13:23
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-181,250
-1,250,000 vol
$0.145 each 		3,100,000
Filed 2020-06-06 13:21
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-28,000
-200,000 vol
$0.14 each 		4,350,000
Filed 2020-06-06 13:20
Tx date 2020-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-346,500
-1,050,000 vol
$0.33 each 		4,550,000
Filed 2019-11-28 13:23
Tx date 2019-11-28 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+1,850,000 vol 		6,050,000
Filed 2019-06-03 12:42
Tx date 2019-06-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-300,000 vol 		0
Filed 2019-05-16 16:20
Tx date 2019-05-14 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,400
+10,000 vol
$0.34 each 		276,770
Filed 2018-10-05
Tx date 2018-10-03 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
97 - Other
+4,200,000 vol 		4,200,000
Filed 2018-10-05
Tx date 2013-06-10 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-20
Tx date 2018-09-19 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$27,000
+100,000 vol
$0.27 each 		266,770
Filed 2018-05-02
Tx date 2018-05-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-71,820
-189,000 vol
$0.38 each 		166,770
Filed 2018-04-28
Tx date 2018-04-27 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,545
-74,500 vol
$0.41 each 		355,770
Filed 2018-04-28
Tx date 2018-04-26 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-96,965
-236,500 vol
$0.41 each 		430,270
Filed 2018-04-20
Tx date 2018-04-19 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$72,500
+500,000 vol
$0.145 each 		666,770
Filed 2018-04-20
Tx date 2018-04-19 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-72,500
-500,000 vol
$0.145 each 		5,600,000
Filed 2018-04-17
Tx date 2018-04-17 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-74,750.40
-155,730 vol
$0.48 each 		166,770
Filed 2018-04-11
Tx date 2018-04-10 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: AltaPharm International Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-50,000
-100,000 vol
$0.50 each 		625,000
Filed 2018-03-29
Tx date 2018-03-27 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$7,500
+50,000 vol
$0.15 each 		322,500
Filed 2018-03-29
Tx date 2018-03-27 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-7,500
-50,000 vol
$0.15 each 		0
Filed 2018-03-25
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-75,000 vol 		50,000
Filed 2018-03-25
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-75,000 vol
Filed 2018-03-23
Tx date 2017-12-01 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-75,000 vol 		50,000
Filed 2017-04-03
Tx date 2017-03-31 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$460,000
+2,300,000 vol
$0.20 each 		6,100,000
Filed 2016-06-14
Tx date 2016-06-10 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$10,000
+100,000 vol
$0.10 each 		272,500
Filed 2016-06-14
Tx date 2016-06-10 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$5,000
+50,000 vol
$0.10 each 		125,000
Filed 2016-03-11
Tx date 2016-03-09 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$319,000
+2,200,000 vol
$0.145 each 		3,800,000
Filed 2015-07-24
Tx date 2015-07-13 		$ATE
Antibe Therapeutics Inc. 		Wallace, John Lawrence
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$28,000
+200,000 vol
$0.14 each 		1,600,000